489,017 Shares in InfuSystem Holdings, Inc. $INFU Purchased by Diamond Hill Capital Management LLC Investment Advisor

Diamond Hill Capital Management LLC Investment Advisor acquired a new position in shares of InfuSystem Holdings, Inc. (NYSE:INFU) in the 2nd quarter, according to its most recent filing with the SEC. The fund acquired 489,017 shares of the company’s stock, valued at approximately $4,719,000.

A number of other hedge funds have also made changes to their positions in INFU. Arrowstreet Capital Limited Partnership lifted its position in shares of InfuSystem by 220.1% in the third quarter. Arrowstreet Capital Limited Partnership now owns 449,348 shares of the company’s stock valued at $4,655,000 after acquiring an additional 308,974 shares in the last quarter. Ancora Advisors LLC acquired a new position in InfuSystem in the 3rd quarter valued at $2,096,000. Jane Street Group LLC raised its stake in InfuSystem by 943.1% in the 2nd quarter. Jane Street Group LLC now owns 186,159 shares of the company’s stock valued at $1,162,000 after purchasing an additional 168,312 shares during the last quarter. GSA Capital Partners LLP purchased a new position in InfuSystem in the 2nd quarter valued at $1,548,000. Finally, North Star Investment Management Corp. lifted its holdings in InfuSystem by 527.6% in the 1st quarter. North Star Investment Management Corp. now owns 182,000 shares of the company’s stock valued at $1,680,000 after purchasing an additional 153,000 shares in the last quarter. Institutional investors and hedge funds own 71.13% of the company’s stock.

InfuSystem Trading Down 0.9%

Shares of InfuSystem stock opened at $12.16 on Tuesday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. The stock’s 50 day simple moving average is $9.92 and its 200-day simple moving average is $9.42. The stock has a market cap of $245.41 million, a P/E ratio of 202.70 and a beta of 1.42. InfuSystem Holdings, Inc. has a 1-year low of $7.29 and a 1-year high of $12.97.

InfuSystem announced that its Board of Directors has initiated a share repurchase program on Tuesday, May 19th that authorizes the company to repurchase $20.00 million in shares. This repurchase authorization authorizes the company to repurchase up to 10.2% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.

Analysts Set New Price Targets

Separately, B. Riley Financial reaffirmed a “buy” rating and set a $20.00 target price (up from $12.00) on shares of InfuSystem in a report on Wednesday, August 5th. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, InfuSystem has a consensus rating of “Moderate Buy” and a consensus price target of $16.67.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.